Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Salvianolic Acid B Inhibits Hydrogen Peroxide-Induced Endothelial Cell Apoptosis through Regulating PI3K/Akt Signaling

Salvianolic Acid B Inhibits Hydrogen Peroxide-Induced Endothelial Cell Apoptosis through Regulating PI3K/Akt Signaling

  • Chen-Li Liu, 
  • Li-Xia Xie, 
  • Min Li, 
  • Siva Sundara Kumar Durairajan, 
  • Shinya Goto, 
  • Jian-Dong Huang
  • Published: December 19, 2007
  • DOI: 10.1371/journal.pone.0001321



Salvianolic acid B (Sal B) is one of the most bioactive components of Salvia miltiorrhiza, a traditional Chinese herbal medicine that has been commonly used for prevention and treatment of cerebrovascular disorders. However, the mechanism responsible for such protective effects remains largely unknown. It has been considered that cerebral endothelium apoptosis caused by reactive oxygen species including hydrogen peroxide (H2O2) is implicated in the pathogenesis of cerebrovascular disorders.

Methodology and Principal Findings

By examining the effect of Sal B on H2O2-induced apoptosis in rat cerebral microvascular endothelial cells (rCMECs), we found that Sal B pretreatment significantly attenuated H2O2-induced apoptosis in rCMECs. We next examined the signaling cascade(s) involved in Sal B-mediated anti-apoptotic effects. We showed that H2O2 induces rCMECs apoptosis mainly through the PI3K/ERK pathway, since a PI3K inhibitor (LY294002) blocked ERK activation caused by H2O2 and a specific inhibitor of MEK (U0126) protected cells from apoptosis. On the other hand, blockage of the PI3K/Akt pathway abrogated the protective effect conferred by Sal B and potentated H2O2-induced apoptosis, suggesting that Sal B prevents H2O2-induced apoptosis predominantly through the PI3K/Akt (upstream of ERK) pathway.


Our findings provide the first evidence that H2O2 induces rCMECs apoptosis via the PI3K/MEK/ERK pathway and that Sal B protects rCMECs against H2O2-induced apoptosis through the PI3K/Akt/Raf/MEK/ERK pathway.


Apoptosis is a process of programmed cell death in which defective and harmful cells are eliminated from a multicellular organism so as to maintain its homeostasis. Dysregulation of apoptotic signalling leads to pathological conditions, such as carcinoma (no apoptosis) and ischemia (enhanced apoptosis) [1]. Cerebral microvascular endothelial cells (CMECs) and intercellular tight junctions constitute the basic structure of the blood-brain barrier (BBB) which is responsible for regulating the trafficking of cells, substrates, and other molecules into the brain [2]. Apoptosis of CMECs may destroy the BBB and expose smooth muscle cells to neurotransmitters, toxins, and other vasoactive agents in the blood stream. Notably, CMECs apoptosis may lead to neuronal injury through the loss of BBB integrity and permit the extravasations of vascular inflammatory cells and proteins that are toxic to neurons [3]. Hence, CMECs apoptosis is considered to be partially responsible for the pathogenesis of various neurodisorders, such as cerebral ischemia, cerebral apoplexy, and Alzheimer's disease [4], [5].

It has been demonstrated that reactive oxygen species (ROS) are involved in the apoptosis of CMECs [6]. Production of high quantities of ROS within the vasculature occurs in a wide array of pathological events [7]. The excessive accumulation of ROS results in oxidative stress, which is known to induce cell death in a wide variety of cell types by modulating a series of intracellular signaling pathways [8]. Among these pathways, the activation of mitogen-activated protein kinases (MAPKs) and phosphatidylinositol-3-kinase (PI3K)/Akt pathways are known to play major roles in cell growth, survival, differentiation and apoptosis responses [9]. ROS that are particularly responsible for oxidative stress include hydrogen peroxide (H2O2), superoxide anions, and hydroxyl radicals. Among them, H2O2, the major source of endogenous ROS [10], is generated during hypoxia and ischemia-reperfusion injury [11], and has been extensively used to induce oxidative stress in in vitro models [7], [12].

The dried root of Salvia miltiorrhiza Bunge (Danshen) is a popular traditional Chinese medicine and has been widely used in both Asian and Western countries for the treatment of various diseases including cerebrovascular diseases, coronary artery diseases, and myocardial infarction [13], [14]. Salvianolic acid B (Sal B) is the most abundant and bioactive component of salvianolic acid in Danshen [15]. Extensive pharmacological studies have been carried out on this compound. It was shown that Sal B prevented ischaemia/reperfusion-induced rat brain injury by reducing lipid peroxidation, scavenging free radicals and improving energy metabolism [16]. In cerebral ischemia rats, Sal B reduced learning and memory dysfunctions induced by ischemia [17]. Moreover, salvianolic acids, including Sal B, were shown to improve regional cerebral blood flow in the ischemic hemisphere and inhibit platelet aggregation in rats [18]. More recently, Sal B was reported to be capable of improving the recovery of motor function after cerebral ischemia in rats [19]. At present, the molecular mechanisms responsible for the reported beneficial cerebrovascular effects of Sal B are relatively less studied. Considering the significance of oxidative stress-related cerebral vascular apoptosis, the present study was undertaken to examine the protective effects of Sal B on ROS (represented by H2O2)-induced rat cerebral microvascular endothelial apoptosis. We provide evidence that the anti-apoptotic effects of Sal B are at least in part mediated by altering the PI3K/Akt/Raf/MEK/ERK signaling pathway.


Effects of Sal B on H2O2-induced apoptosis in rCMECs

We first measured H2O2-induced apoptosis in rCMECs using the TUNEL assay. As shown in Fig. 1A, the percentage of apoptotic (TUNEL-positive) cells increases dose-dependently with concentrations of H2O2 ranging from 100 to 500 µM for 12 h. In addition, we also evaluated nuclear condensation, which is characteristic for apoptotic cell death, using DAPI staining. To evaluate the effect of Sal B, cells were first pretreated with various concentrations of Sal B (from 10 to 100 µM), followed by treatment with H2O2 (200 µM for 12 h) and apoptosis was then quantified by TUNEL assay (Fig. 1B, 1C) and DAPI staining. Unstressed cells showed no signs of morpohological nuclear damage or chromatin condensation, which distinguished them from the stressed, H2O2-treated cells. The morphology of cells incubated with both H2O2 and Sal B was comparable to that of unstressed cells. To further verify the effect of Sal B on apoptosis induced by H2O2, TUNEL assays were performed. The results show that pretreatment with Sal B dose-dependently reduced H2O2-induced apoptosis (Fig. 1B).

Figure 1. Inhibition of H2O2-induced rCMECs apoptosis by Sal B.

(A) Apoptosis was induced in rCMECs with 0∼500 µM H2O2 for 12 h and determined by TUNEL assay. (B) rCMECs were pretreated with Sal B (0∼100 µM) for 30 min, and then coincubated with or without 200 µM H2O2 for 12 h, followed by apoptosis measurement using TUNEL assay. (C) rCMECs were analyzed by DAPI staining and TUNEL assay after a 12-h exposure to H2O2 with or without Sal B pretreatment. (D) Time course of caspase-9 activation in rCMECs incubated with H2O2 (200 µM) alone or with H2O2 (200 µM) and Sal B (20 µM). (E) Time course of caspase-3 activation in rCMECs incubated with H2O2 (200 µM) alone or with H2O2 (200 µM) and Sal B (20 µM). Immunoblotting were carried out on cell lysate proteins from control cells or rCMECs pretreated with Sal B for 1 h and then exposed to H2O2 for the indicated times. (G) rCMECs were pretreated with zVAD-fmk (0∼100 µM) for 60 min, and then coincubated with or without 200 µM H2O2 for 12 h, followed by apoptosis measurement using TUNEL assay. *P<0.05; **P<0.01 versus control, #, P<0.05 versus H2O2 alone. Data are representative of three independent experiments.


We next examined caspase-9 and -3 activation in H2O2-stimulated endothelial cells. Western blotting analysis revealed that amounts of cleaved caspase-9 and -3 in H2O2-stimulated rCMECs were maximal at 24 h and returned to near basal concentrations at 36 h (Fig. 1D, E). However, these effects of H2O2 were attenuated by Sal B. Preincubation of cells with Sal B decreased the amounts of cleaved caspase-9 (Fig. 1D) and -3 (Fig. 1E), and also shortened the duration of their activation in response to exposure to H2O2. These data imply that Sal B may block the caspase-9 and -3 mediated apoptotic signaling pathways by acting on some upstream target(s). Given that activations of caspase-9 and -3 were still observed when Sal B significantly suppressed H2O2-induced apoptosis in the first 12 h, we sought to reveal the involvement of caspase. zVAD-fmk, a pan-caspase-inhibitor [20], was employed to examine its ability to prevent apoptosis by H2O2. The data shown in Fig. 1G demonstrates that zVAD-fmk only slightly reduced the apoptotic percentage after exposure to H2O2, implying that the majority of rCMECs may undergo caspase-independent apoptosis when exposed to 200 µM H2O2.

Effects of Sal B on MEK/ERK signaling

To investigate the molecular mechanism by which Sal B exerts its anti-apoptotic effects, the activation of MAPK was examined. An increasing body of evidence has shown that H2O2 stimulation increases extracellular signal-regulated kinase (ERK) activation and concomitant apoptosis [21], [22]. We performed the apoptosis analysis using U0126, a specific inhibitor of ERK upstream kinase MEK [23]. The increase of TUNEL-positive cells stimulated by H2O2 was significantly inhibited by U0126, but not by its inactive analogue U0124 [23] (Fig. 2A). These results indicated that H2O2-induced rCMECs apoptosis, which was attenuated by Sal B, was mediated through the MEK/ERK signaling pathway. Therefore, we wondered what the action of Sal B on the modulation of ERK activation in rCMECs is and whether the anti-apoptotic effect of Sal B is mediated through ERK. We thus analyzed ERK activation by Western blotting analysis with phospho-ERK-specific antibody. The results showed that amounts of phosphorylated ERK in H2O2-stimulated cells peaked at 30 min, that they returned to near basal concentrations after 3 h, but that pretreatment with Sal B resulted in a marked inhibition of these cellular responses, and that incubation of rCMECs with Sal B alone significantly reduced basal ERK phosphorylation (Fig. 2B).

Figure 2. Effects of Sal B on MEK/ERK signaling.

(A) Effects of Sal B, MEK inhibition, or their combination on H2O2-induced apoptosis. rCMECs were incubated with U0126 (10 µM) or U0124 (10 µM) for 1 h and then exposed to H2O2 in the presence or absence of Sal B pretreatment for 12 h. *P<0.05; **P<0.01 versus H2O2 alone. Data are representative of three independent experiments. (B) Time course of phosphorylated ERK1/2 expression in rCMECs incubated with H2O2 (200 µM) alone, or with H2O2 (200 µM) and Sal B (20 µM), or with Sal B (20 µM) alone. Immunoblotting were carried out on cell lysate proteins from control cells or rCMECs pretreated with Sal B for 1 h and then exposed to H2O2 for the indicated times. The representative Western blots and the quantitative analysis of protein expression (in relative protein density units). *P<0.05 versus control, #, P<0.05 versus H2O2 alone. Data are representative of three independent experiments.


Role of PI3K signaling

We next examined the effect of Akt inhibition on ERK phosphorylation in rCMECs exposed to H2O2. Treatment with LY294002, a specific inhibitor of Akt upstream kinase PI3K [24], resulted in the blockage of H2O2-induced ERK phosphorylation, as well as basal and H2O2-induced Akt phosphorylation. The basal level of ERK phosphorylation was also diminished (Fig. 3A). In the presence of U0126, basal and H2O2-induced ERK phosphorylation were blocked. However, U0126 had no effect on either basal or H2O2-induced Akt phosphorylation (Fig. 3A). These data clearly illustrate that PI3K acts upstream of ERK in the H2O2-induced signaling cascade. Previous studies have shown that Akt inhibited activation of the MEK/ERK signaling pathway by phosphorylating c-Raf at residue Ser-259 [25]. To investigate whether in rCMECs Sal B inhibited H2O2-induced MEK/ERK activation through Akt, we therefore evaluated the effect of Sal B on Akt activation. Results showed that the phosphorylation of Akt peaked at 15 min in the cells incubated with Sal B alone, and then returned to basal level over 60 min (Fig. 3B). An elevated level of phosphorylated c-Raf at Ser-259 was also triggered by Sal B alone (Fig. 3B). Furthermore, LY294002 treatment completely blocked expressions of phosphorylated Akt (Ser-473) and c-Raf (Ser-259) induced by Sal B (Fig. 3C). This indicates PI3K is required for Sal B-induced Akt activation and c-Raf deactivation. Since c-Raf is known to lie downstream of Akt, and upstream of ERK [25], [26], we then sought to confirm that this was also the case in rCMECs. GW5074, a selective inhibitor of c-Raf, inhibits the Raf/MEK/ERK cascade in in vitro assays by 90% at 5 µM [27]. Treatment with GW5074 had no effect on either basal or H2O2-induced Akt phosphorylation (Fig. 3D), but blocked H2O2-induced ERK phosphorylation (Fig. 3D). To further determine if the anti-apoptotic effects of Sal B were due to its effect on Akt, rCMECs were incubated with LY294002, with and without Sal B prior to H2O2 treatment. Inhibition of PI3K completely ablated the anti-apoptotic effect of Sal B, as well as H2O2-induced apoptosis was potentiated (Fig. 3E). Thus, these results indicate that Sal B prevents H2O2-induced rCMECs apoptosis, at least in part, by altering PI3K/Akt/Raf/MEK/ERK activation.

Figure 3. Role of PI3K signaling.

(A) Effects of PI3K or MEK inhibition on phosphorylated Akt (Ser-473) and phosphorylated ERK1/2 expression in the presence or absence of H2O2 (200 µM). rCMECs were incubated with LY294002 (50 µM) or U0126 (10 µM) for 1 h and then exposed to H2O2 for 30 min. Blot shown is representative of at least three independent experiments. (B) Phosphorylated Akt (Ser-473) and phosphorylated c-Raf (Ser-259) expressions in rCMECs incubated with Sal B (20 µM) for the indicated times. (C) Effect of PI3K inhibition on phosphorylated Akt (Ser-473) and phosphorylated c-Raf (Ser-259) expressions induced by Sal B. rCMECs were incubated with LY294002 (50 µM) and/or Sal B (20 µM) for 1 h. (D) Effect of c-Raf inhibition on phosphorylated Akt (Ser-473) and phosphorylated ERK1/2 activation induced by H2O2. rCMECs were incubated with GW5074 (5 µM) and/or H2O2 (200 µM) for 1 h. (E) Effect of PI3K inhibition on H2O2-induced apoptosis in the presence or absence of Sal B (20 µM). rCMECs were incubated with LY294002 (50 µM) and/or Sal B (20 µM) for 1 h and then exposed to H2O2 for 12 h. LY, indicates LY294002. S, indicates Sal B. *P<0.05; **P<0.01 versus H2O2 alone; n.s., not significant. Data are representative of three independent experiments.



This study yielded four major findings: (1) Exposure rCMECs to H2O2 caused dose-dependent apoptosis, which could be prevented by pretreatment with Sal B. (2) Activation of the MEK/ERK pathway acted as a pro-apoptotic signal in H2O2-treated rCMECs; this activation was in turn dependent on PI3K activation. (3) The PI3K/Akt pathway acted as a survival signal upstream of c-Raf in H2O2-treated rCMECs. (4) Sal B exerted its preventive effects at least partly through the PI3K/Akt/Raf/MEK/ERK pathway.

CMECs is a useful cell culture model for elucidating mechanisms of cerebral vascular diseases and protection that are extremely difficult to identify in vivo [28]. Apoptosis of CMECs plays a pivotal role in pathogenesis of these diseases. Accumulating evidence indicates that the elevated release of ROS from brain tissue under pathologic conditions is a fundamental mechanism leading to the apoptosis of CMECs [6]. So protection of CMECs from ROS-induced apoptosis may provide beneficial therapeutic intervention to successfully combat cerebrovascular diseases. In this study, we demonstrated that Sal B was capable of saving rCMECs from apoptotic cell death caused by H2O2. This suggests that Sal B may have therapeutic use in the prevention of cerebrovascular diseases.

To date, very little is known about apoptotic effects of H2O2 in CMECs. Our results indicate that H2O2 induced CMECs apoptosis in a dose-dependent manner; this apoptosis was characterized by condensation of the nucleus chromatin, fragmentation of the DNA, and activation of caspases-3 and -9. Caspases, a family of specific cysteine proteases, are critical mediators of apoptosis. Fourteen members of the caspase family have been identified [29]. Among them, caspase-3 is a primary executioner of apoptosis induced by a variety of stimuli including H2O2 [30], [31]. Caspase-9 is a major activator in intrinsic pathway. Following cerebral ischemia, cytochrome c is released from mitochondrial intermembrane space as a result of the changed mitochondrion permeability [32]. Released cytochrome c promotes the activation of caspase-9 through Apaf-1 [33]. Activated caspase-9 subsequently activates caspase-3, which will in turn activate procaspase-9; this sequence forms positive feedback activation pathway. We showed that Sal B attenuated the activation of both caspases-3 and -9, and shortened their activation durations. The mechanisms by which H2O2 induces caspase activation in endothelial cells are not fully understood. This activation could be due to direct oxidative stress, or it could be mediated by mitochondria or by other mechanisms; any of these mechanisms might be inhibited by Sal B. Although H2O2 activated caspases in rCMECs, our data indicate that H2O2-induced apoptosis was mainly dependent on caspase-independent mechanisms but not caspase activation.

Exposure of endothelial cells to H2O2 activates several intricate cell signaling cascades that are crucial for determining whether a cell survives or dies. One such cascade involves ERK-mediated signaling [34]. The ERK pathway is most frequently associated with regulation of cell growth, survival, and differentiation [35]. A growing body of studies has revealed that ERK might play a role in apoptosis and pathogenesis. However the existing evidence is conflicting. For example, Yang et al. [7] and Wang et al. [36] reported that ERK served as pro-survival signaling mediators to alleviate H2O2 cytotoxic effects in aortic endothelial cells. Oppositely, studies by Fischer et al. [37] showed that in CMECs, paracellular permeability induced by H2O2 was due to the activation of ERK. Similarly, we showed that inhibition of ERK by U0126 elicited cell survival, suggesting ERK was a pro-apoptosis signal mediator in H2O2-stimulated rCMECs. Taken together, these results suggest that the role of ERK under oxidative stress is cell-type specific. Our data further showed that ERK activation following oxidative injury was suppressed by Sal B treatment, which was consistent with data recently published by others in different cell culture models: human aortic smooth muscle cells [38], [39]; hepatic stellate cells [40]; and human umbilical vein endothelial cells [41]. These results indicate that the ERK pathway may be a target of Sal B activity.

To gain further insight into the mechanisms by which Sal B modulates ERK signalling and by which ERK mediates H2O2-induced apoptosis, we evaluated the role of the PI3K/Akt pathway. Akt is a serine/threonine kinase. It can be activated by phosphorylation and subsequently activates multiple downstream targets to enhance cell survival. PI3K, a lipid kinase, is largely responsible for Akt phosphorylation; it has three classes or subfamilies; I, II, and III [42], [43]. Each class of PI3K has unique preferences for phosphoinositide substrates and produces specific lipid second messengers [43]. In endothelial cells, PI3K/Akt elicits a survival signalling following various stresses, including exposure to H2O2, and this signaling leads to the inhibition of apoptosis [44], [45]. Notably, following cerebral ischemia, Akt is responsible for the preventive effects on cerebrovascular endothelium apoptosis [28]. In rCMECs, we demonstrated that exposure to H2O2 induced a transient activation of Akt, which peaked at 1 h. If PI3K/Akt plays an important survival role in rCMECs, inhibition of PI3K/Akt should potentiate H2O2-induced apoptosis; indeed this was observed. Given that activation of Akt was observed in the presence of significantly elevated levels of phosphorylated ERK in cells exposed to H2O2, we were curious as to whether Akt and ERK represented two independent pathways in apoptotic signaling cascades induced by H2O2. Zhuang et al. [22] and Sinha et al. [46] recently reported that ERK was an upstream effector of Akt and that inhibition of ERK enhanced Akt activity. Unlike their observation, our data showed that Akt phophorylation level was unaffected by ERK inhibition. In contrast, H2O2-induced activation of ERK was completely inhibited by the PI3K-inhibitor, LY294002, suggesting that PI3K was responsible for ERK activation. Thus, the activation of PI3K was an upstream event in H2O2-induced rCMECs apoptosis; it subsequently activated Akt and, through an unknown mechanism, ERK. Since LY294002 inhibits all classes of PI3Ks, activation of ERK and Akt might be induced by a different PI3K family member. It was recently reported that, although all class I PI3K family members are capable of activating Akt, only PI3Kγ is responsible for the activation of MEK/ERK [47].

Clearly, although both PI3K/Akt and PI3K/ERK are activated following oxidant injury in rCMECs, they play opposite roles. PI3K/ERK signaling played an indispensably proapoptotic role in H2O2-induced rCMECs apoptosis. Sequentially activation of PI3K and Akt acted as survival signal to protect cells from apoptosis by deactivating c-Raf at Ser-259. In addition to this, Akt also promotes cell survival by its abilities to phosphorylate Bad at Ser136 [48]; Akt also directly inhibits activation of caspase-9 by phosphorylating pro-caspase-9 at Ser-196 and by this inhibits proteolytic processing of pro-Caspase-9 [49].

We suppose that the status of rCMECs apoptosis is determined by the balance between the PI3K/Akt and PI3K/MEK/ERK pathways. In the presence of H2O2, the effects of PI3K/MEK/ERK overwhelm those of PI3K/Akt, so that the balance is tipped in favor of apoptosis. So Sal B may protect rCMECs from H2O2-induced apoptosis by restoring the PI3K/Akt and PI3K/MEK/ERK balance. Our hypothesis is supported by our findings that Sal B alone triggered a rapid activation of Akt, peaked at 15 min, which then initiated downstream signaling events including deactivation of c-Raf, and down-regulation of MEK and ERK. On the other hand, inhibition of PI3K completely blocked Sal B-mediated Akt activation and all following effects. These data confirmed that PI3K/Akt is a particularly important signaling pathway in the mechanism by which Sal B promotes endothelium survival.

With a dosage that completely suppressed ERK activation, U0126 showed a substantial but not complete effect on H2O2-induced apoptosis (Fig. 2A). This clearly indicated that MEK/ERK was not the sole pathway responsible for H2O2-induced apoptosis. Using both U0126 and Sal B, we then observed a complete rescue from apoptotic cell death caused by H2O2. Thus, it appears that in addition to the PI3K/Akt/Raf/MEK/ERK pathway, Sal B might protect rCMECs from apoptosis through other mechanism(s). This possibility needs further investigation.

In conclusion, our findings have potentially important implications for understanding the mechanisms by which H2O2 induces rCMECs apoptosis and by which Sal B helps prevent apoptotic cell death (Fig. 4). To the best of our knowledge, this is the first report indicating the significance of PI3K/Akt and MEK/ERK signaling in H2O2-induced CMECs apoptosis and providing evidence that the PI3K signaling pathway is the mechanism by which Sal B acts as an anti-apoptotic agent in protecting cells from H2O2 injury and prolonging cerebral endothelial survival.

Figure 4. Schematic model of signaling events involved in H2O2-induced rCMECs apoptosis and Sal B preventive mechanism.

The broken line indicates a possible link of Akt and caspase-9.


Materials and Methods


Salvianolic acid B (Sal B, purity>99%) was purchased from the Chinese National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). When used, it was freshly prepared in phosphate buffer solution (PBS). Dulbecco's modified Eagle's medium (DMEM), medium 199 (M199), fetal bovine serum (FBS), PBS, Trypsin, EDTA, HEPES, PMSF, penicillin, and streptomycin were purchased from Gibco BRL (Grand Island, NY, USA). Endothelial cell growth factor (ECGF) was from Roche Diagnostics (Mannheim, Germany). U0126, LY294002 and antibodies for phospho-ERK1/2, phospho-c-Raf (Ser-259), phosphor-Akt (Ser-473), caspase-3 and caspase-9 were obtained from Cell Signaling Technology (Beverly, MA). U0124 was from CalBiochem (San Diego, CA). Horseradish peroxidase (HRP)-conjugated secondary goat anti-mouse or anti-rabbit antibodies were from Invitrogen (S. San Francisco, USA); ECL reagent kit was from Pierce Biotechnology (Rockford, USA); Heparin, collagenase II, gelatin, H2O2, zVAD-fmk, GW5074, and antibodies for β-actin and γ-tubulin were purchased from Sigma (St. Louis, MO, USA). H2O2 was freshly prepared for each experiment from a 33% stock solution.

Cell culture and drug treatments

Rat cerebral microvascular endothelial cells (rCMECs) were isolated from Sprague-Dawley rat cerebral cortex microvessel segments, according to the method described by Bederson et al. [50]. Briefly, the cortices were dissected free of meninges and white matter in M199 supplemented with 8% FBS, 10 U/ml heparin and 100 U/ml penicillin-streptomycin solution. The remaining gray matter was cut into small pieces and homogenized. Thereafter, the slurry was filtered consecutively through 145- and 75-µm nylon mesh screens to remove large vessels, tissue mass, single blood and nerve cells. The collected cerebral microvessels were treated with 0.1% collagenase at 37°C for 15 min. After incubation, the detached cells were centrifuged and resuspended in DMEM supplemented with 25% FBS, 10 U/ml heparin, 100 U/ml penicillin-streptomycin solution and 150 µg/ml ECGF, and were grown in monolayers at 37°C in a humidified atmosphere of 5% CO2 and 95% air. Cells from 4th and 7th passage were used in this study. For all experiments, rCMECs were grown to 80%–90% confluence and then pretreated with designated agents for 60 min prior to H2O2 exposure in fresh medium.

TUNEL assay

H2O2-induced apoptosis was detected by performing the terminal deoxynucleotidedyl transferase-mediated dUTP nick end-labeling (TUNEL) assay using an Apo-Direct™ Kit (CalBiochem, San Diego, CA). TUNEL was performed according to the manufacturer's instructions. Briefly, after pretreatments and exposure to H2O2, cells were harvested, washed, fixed, permeabilized, and labeled for DNA strand breaks, then analyzed on a Coulter Epics Elite flow cytometer (Beckman-Coulter, Miami, USA). All assays were carried out in triplicate.

Western Blot

Protein extracts were prepared and subjected to Western blot analysis as described by Sambrook et al [51]. In brief, after designated treatment, endothelial cells were scraped off the plates, washed with PBS and dispersed in 5 volumes of ice-cold suspension buffer (100 mM NaCl, 10 mM Tris-Cl, 1 mM EDTA, and 100 µ/mL phenylmethylsulfonyl fluoride). An equal volume of 2× SDS gel-loading buffer (100 mM Tris-Cl, pH 6.8, 200 mM DTT, 4% SDS, 0.2% bromphenol blue, and 20% glycerol) was added, and the samples were boiled for 10 min. After centrifugation, protein extracts were resolved on SDS-polyacrylamide gel electrophoresis (PAGE) and transferred onto polyvinylidine difluoride membranes. After blocking with 5% skim milk in TBS-T (150 mM NaCl, 50 mM Tris-HCl, pH 8.0, and 0.1% Tween 20) for 1 h, the membranes were probed with various first and second antibodies and developed with enhanced chemiluminescence by following the manufacturer's instructions (Pierce). The levels of proteins were determined using densitometry with Image J software, which allowed direct comparisons between experimental sets.

Statistical analysis

Data was analyzed with unpaired two-tailed Student's t-test or one-way ANOVA followed by Tukey's multiple comparison test with GraphPad Prism software (San Diego, CA). Data were expressed as mean±SEM derived from at least three independent experiments. Differences were considered significant at P<0.05.


We thank Dr. Han-Min Shen for his helpful discussion and critical reading of our manuscript.

Author Contributions

Conceived and designed the experiments: JH CL ML. Performed the experiments: CL LX. Analyzed the data: JH CL. Contributed reagents/materials/analysis tools: ML SG. Wrote the paper: JH CL ML SD.


  1. 1. Mehta SL, Manhas N, Raghubir R (2007) Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 54: 34–66.
  2. 2. Warner TD (1999) Relationships between the endothelin and nitric oxide pathways. Clin Exp Pharmacol Physiol 26: 247–252.
  3. 3. Zhang J, Tan Z, Tran ND (2000) Chemical hypoxia-ischemia induces apoptosis in cerebromicrovascular endothelial cells. Brain Res 877: 134–140.
  4. 4. Shi LG, Zhang GP, Jin HM (2006) Inhibition of microvascular endothelial cell apoptosis by angiopoietin-1 and the involvement of cytochrome C. Chin Med J (Engl) 119: 725–730.
  5. 5. Zipser BD, Johanson CE, Gonzalez L, Berzin TM, Tavares R, et al. (2007) Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol Aging 28: 977–986.
  6. 6. Bresgen N, Karlhuber G, Krizbai I, Bauer H, Bauer HC, et al. (2003) Oxidative stress in cultured cerebral endothelial cells induces chromosomal aberrations, micronuclei, and apoptosis. J Neurosci Res 72: 327–333.
  7. 7. Yang B, Oo TN, Rizzo V (2006) Lipid rafts mediate H2O2 prosurvival effects in cultured endothelial cells. FASEB J 20: 1501–1503.
  8. 8. Abe JI, Berk BC (1998) Reactive oxygen species as mediators of signal transduction in cardiovascular disease. Trends Cardiovasc Med 8: 59–64.
  9. 9. Blanc A, Pandey NR, Srivastava AK (2003) Synchronous activation of ERK 1/2, p38mapk and PKB/Akt signaling by H2O2 in vascular smooth muscle cells: potential involvement in vascular disease (review). Int J Mol Med 11: 229–234.
  10. 10. Nohl H, Kozlov AV, Gille L, Staniek K (2003) Cell respiration and formation of reactive oxygen species: facts and artefacts. Biochem Soc Trans 31: 1308–1311.
  11. 11. Hashimoto Y, Itoh K, Nishida K, Okano T, Miyazawa Y, et al. (1994) Rapid superoxide production by endothelial cells and their injury upon reperfusion. J Surg Res 57: 693–697.
  12. 12. Xiao XQ, Lee NT, Carlier PR, Pang Y, Han YF (2000) Bis(7)-tacrine, a promising anti-Alzheimer's agent, reduces hydrogen peroxide-induced injury in rat pheochromocytoma cells: comparison with tacrine. Neurosci Lett 290: 197–200.
  13. 13. Jiang RW, Lau KM, Hon PM, Mak TC, Woo KS, et al. (2005) Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza. Curr Med Chem 12: 237–246.
  14. 14. Zhou L, Zuo Z, Chow MS (2005) Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45: 1345–1359.
  15. 15. Watzke A, O'Malley SJ, Bergman RG, Ellman JA (2006) Reassignment of the configuration of salvianolic acid B and establishment of its identity with lithospermic acid B. J Nat Prod 69: 1231–1233.
  16. 16. Chen YH, Du GH, Zhang JT (2000) Salvianolic acid B protects brain against injuries caused by ischemia-reperfusion in rats. Acta Pharmacol Sin 21: 463–466.
  17. 17. Du GH, Qiu Y, Zhang JT (2000) Salvianolic acid B protects the memory functions against transient cerebral ischemia in mice. J Asian Nat Prod Res 2: 145–152.
  18. 18. Tang MK, Ren DC, Zhang JT, Du GH (2002) Effect of salvianolic acids from Radix Salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats. Phytomedicine 9: 405–409.
  19. 19. Tang M, Feng W, Zhang Y, Zhong J, Zhang J (2006) Salvianolic acid B improves motor function after cerebral ischemia in rats. Behav Pharmacol 17: 493–498.
  20. 20. Slee EA, Zhu H, Chow SC, MacFarlane M, Nicholson DW, et al. (1996) Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J 315(Pt 1): 21–24.
  21. 21. Lee JS, Kim SY, Kwon CH, Kim YK (2006) EGFR-dependent ERK activation triggers hydrogen peroxide-induced apoptosis in OK renal epithelial cells. Arch Toxicol 80: 337–346.
  22. 22. Zhuang S, Yan Y, Daubert RA, Han J, Schnellmann RG (2007) ERK promotes hydrogen peroxide-induced apoptosis through caspase-3 activation and inhibition of Akt in renal epithelial cells. Am J Physiol Renal Physiol 292: F440–447.
  23. 23. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, et al. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623–18632.
  24. 24. Vlahos CJ, Matter WF, Hui KY, Brown RF (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241–5248.
  25. 25. Zimmermann S, Moelling K (1999) Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286: 1741–1744.
  26. 26. Rommel C, Clarke BA, Zimmermann S, Nunez L, Rossman R, et al. (1999) Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286: 1738–1741.
  27. 27. Lackey K, Cory M, Davis R, Frye SV, Harris PA, et al. (2000) The discovery of potent cRaf1 kinase inhibitors. Bioorg Med Chem Lett 10: 223–226.
  28. 28. Zhang Y, Park TS, Gidday JM (2007) Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation. Am J Physiol Heart Circ Physiol 292: H2573–2581.
  29. 29. Cryns V, Yuan J (1998) Proteases to die for. Genes Dev 12: 1551–1570.
  30. 30. Boatright KM, Salvesen GS (2003) Mechanisms of caspase activation. Curr Opin Cell Biol 15: 725–731.
  31. 31. Fadeel B, Orrenius S (2005) Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Intern Med 258: 479–517.
  32. 32. Fujimura M, Morita-Fujimura Y, Murakami K, Kawase M, Chan PH (1998) Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 18: 1239–1247.
  33. 33. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, et al. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479–489.
  34. 34. Watanabe N, Zmijewski JW, Takabe W, Umezu-Goto M, Le Goffe C, et al. (2006) Activation of mitogen-activated protein kinases by lysophosphatidylcholine-induced mitochondrial reactive oxygen species generation in endothelial cells. Am J Pathol 168: 1737–1748.
  35. 35. Yang JY, Michod D, Walicki J, Widmann C (2004) Surviving the kiss of death. Biochem Pharmacol 68: 1027–1031.
  36. 36. Wang J, Shen YH, Utama B, LeMaire SA, Coselli JS, et al. (2006) HCMV infection attenuates hydrogen peroxide induced endothelial apoptosis–involvement of ERK pathway. FEBS Lett 580: 2779–2787.
  37. 37. Fischer S, Wiesnet M, Renz D, Schaper W (2005) H2O2 induces paracellular permeability of porcine brain-derived microvascular endothelial cells by activation of the p44/42 MAP kinase pathway. Eur J Cell Biol 84: 687–697.
  38. 38. Chen YL, Hu CS, Lin FY, Chen YH, Sheu LM, et al. (2006) Salvianolic acid B attenuates cyclooxygenase-2 expression in vitro in LPS-treated human aortic smooth muscle cells and in vivo in the apolipoprotein-E-deficient mouse aorta. J Cell Biochem 98: 618–631.
  39. 39. Lin SJ, Lee IT, Chen YH, Lin FY, Sheu LM, et al. (2007) Salvianolic acid B attenuates MMP-2 and MMP-9 expression in vivo in apolipoprotein-E-deficient mouse aorta and in vitro in LPS-treated human aortic smooth muscle cells. J Cell Biochem 100: 372–384.
  40. 40. Cheng Y, Ping J, Liu C, Tan YZ, Chen GF (2006) Study on effects of extracts from Salvia Miltiorrhiza and Curcuma Longa in inhibiting phosphorylated extracellular signal regulated kinase expression in rat's hepatic stellate cells. Chin J Integr Med 12: 207–211.
  41. 41. Ding M, Ye TX, Zhao GR, Yuan YJ, Guo ZX (2005) Aqueous extract of Salvia miltiorrhiza attenuates increased endothelial permeability induced by tumor necrosis factor-alpha. Int Immunopharmacol 5: 1641–1651.
  42. 42. Song G, Ouyang G, Bao S (2005) The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 9: 59–71.
  43. 43. Stein RC, Waterfield MD (2000) PI3-kinase inhibition: a target for drug development? Mol Med Today 6: 347–357.
  44. 44. Kontos CD, Cha EH, York JD, Peters KG (2002) The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis. Mol Cell Biol 22: 1704–1713.
  45. 45. Ohashi H, Takagi H, Oh H, Suzuma K, Suzuma I, et al. (2004) Phosphatidylinositol 3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activity. Circ Res 94: 785–793.
  46. 46. Sinha D, Bannergee S, Schwartz JH, Lieberthal W, Levine JS (2004) Inhibition of ligand-independent ERK1/2 activity in kidney proximal tubular cells deprived of soluble survival factors up-regulates Akt and prevents apoptosis. J Biol Chem 279: 10962–10972.
  47. 47. Schmidt EK, Fichelson S, Feller SM (2004) PI3 kinase is important for Ras, MEK and Erk activation of Epo-stimulated human erythroid progenitors. BMC Biol 2: 7.
  48. 48. Datta SR, Dudek H, Tao X, Masters S, Fu H, et al. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231–241.
  49. 49. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, et al. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318–1321.
  50. 50. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, et al. (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17: 472–476.
  51. 51. Sambrook J, Fritsch EF, Maniatis T, editors. (1993) Molecular cloning,a laboratory manual 2nd ed. Beijing: Science Press. pp. 888–890.